Header cover image

Global Pharmaceuticals & Biotech Potential Buyback Winners

UPDATED May 16, 2024

Most likely to generate positive returns on buybacks.

52 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NEU

Neuren Pharmaceuticals		AU$21.8012.9%50.4%AU$2.8bAU$26.13PE17.7xE0.8%n/a

PTGX

Protagonist Therapeutics		US$31.9413.0%27.6%US$1.8bUS$43.50PE11.6xE0.8%n/a

NVAX

Novavax		US$14.40222.1%94.1%US$1.8bUS$19.75PS2xE71.5%n/a

VCYT

Veracyte		US$23.409.5%-4.1%US$1.8bUS$29.83PS4.8xE123.7%n/a

TLRY

Tilray Brands		US$2.127.1%-13.1%US$1.7bUS$2.37PS2.3xE86.8%n/a

BCRX

BioCryst Pharmaceuticals		US$6.4721.6%-23.3%US$1.3bUS$14.00PS3.8xE66.2%n/a

FDMT

4D Molecular Therapeutics		US$25.64-0.2%42.0%US$1.3bUS$52.30PS64.8xE12.6%n/a

LAB

Standard BioTools		US$2.504.2%9.2%US$956.2mUS$3.58PS7.5xE44.2%n/a

CL

Cresco Labs		CA$3.009.1%47.8%CA$1.3bCA$6.00PS1xE105.9%n/a

ARCT

Arcturus Therapeutics Holdings		US$30.5013.8%10.5%US$781.4mUS$72.29PS6.6xE65.8%n/a

MSB

Mesoblast		AU$1.03-6.0%-10.9%AU$1.2bAU$1.10PS104.6xE56.8%n/a

CYRX

Cryoport		US$13.661.5%-31.5%US$692.1mUS$17.89PS3xE34.5%n/a

PACB

Pacific Biosciences of California		US$2.1927.3%-82.7%US$584.2mUS$4.68PS3xE23.8%n/a

CMPS

COMPASS Pathways		US$7.99-6.4%-5.1%US$565.9mUS$41.25PB2.1xE37.2%n/a

HRTX

Heron Therapeutics		US$3.2216.2%147.7%US$485.1mUS$6.75PS3.7xE69.3%n/a

ADCT

ADC Therapeutics		US$4.09-10.5%57.9%US$397.3mUS$10.00PS5.7xE32.7%n/a

ACB

Aurora Cannabis		CA$10.3410.1%24.6%CA$529.6mCA$9.68PE1.4xE-52.1%n/a

AMRN

Amarin		US$0.913.7%-29.8%US$384.5mUS$1.00PS1.4xE47.3%n/a

IMM

Immutep		AU$0.43-6.5%20.8%AU$517.1mn/aPS131.6xE19.5%n/a

MRSN

Mersana Therapeutics		US$2.584.7%-65.1%US$314.5mUS$6.38PS8.2xE15.6%n/a

CDXC

ChromaDex		US$3.48-1.1%123.1%US$274.1mUS$6.34PS3.2xE99.5%n/a

GTHX

G1 Therapeutics		US$4.68-6.0%68.3%US$245.2mUS$8.50PS2.9xE48.3%n/a

SPPI

Spectrum Pharmaceuticals		US$1.035.3%17.0%US$209.9mUS$1.26PS8.2xE67.3%n/a

CGEN

Compugen		US$2.142.4%181.6%US$197.9mUS$5.33PS5.7xE-10.1%n/a
Page 1 of 3
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.